Improvement in health-related quality of life in osteoporosis patients treated with teriparatide

Improvement in health-related quality of life in osteoporosis patients treated with teriparatide

<p>Abstract</p> <p>Background</p> <p>Individuals with osteoporosis and recent vertebral fractures suffer from pain and impaired health-related quality of life (HRQL). To determine whether patients with osteoporosis treated with teriparatide experienced improvement in HR...

Full description

Bibliographic Details
Main Authors:	Papaioannou Alexandra, Thabane Lehana, Sawka Anna M, Ali Sammy H, Lau Arthur N, Gafni Amiram, Adachi Jonathan D
Format:	Article
Language:	English
Published:	BMC 2008-11-01
Series:	BMC Musculoskeletal Disorders
Online Access:	http://www.biomedcentral.com/1471-2474/9/151

Similar Items

Role of teriparatide in treatment of glucocorticoid-induced osteoporosis
by: Arthur N Lau, et al.
Published: (2010-10-01)

Does Alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women
by: Papaioannou Alexandra, et al.
Published: (2005-07-01)

Optimizing care in osteoporosis: The Canadian quality circle project
by: Kvern Brent, et al.
Published: (2008-10-01)

The utilization of appropriate osteoporosis medications improves following a multifaceted educational intervention: the Canadian quality circle project (CQC)
by: Hodsman Anthony, et al.
Published: (2009-08-01)

Teriparatide in the management of osteoporosis
by: Donald Bodenner, et al.
Published: (2008-01-01)

Therapy of Osteoporosis in Men with Teriparatide
by: Natalie E. Cusano, et al.
Published: (2011-01-01)

Teriparatide - Indications beyond osteoporosis
by: Marilyn Lee Cheng, et al.
Published: (2012-01-01)

Teriparatide as option for severe osteoporosis
by: Mara CARSOTE, et al.
Published: (2016-12-01)

Measurement of fractionated plasma metanephrines for exclusion of pheochromocytoma: Can specificity be improved by adjustment for age?
by: Gafni Amiram, et al.
Published: (2005-02-01)

Profile of teriparatide in the management of postmenopausal osteoporosis
by: Andrea Sikon, et al.
Published: (2010-03-01)

Update on the safety and efficacy of teriparatide in the treatment of osteoporosis
by: Salvatore Minisola, et al.
Published: (2019-10-01)

Impressive results of teriparatide treatment of postgastrectomy osteoporosis
by: Tatjana Bačun, et al.
Published: (2011-08-01)

Management of glucocorticoids-induced osteoporosis: role of teriparatide
by: Silvia Migliaccio, et al.
Published: (2009-04-01)

A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma
by: Thabane Lehana, et al.
Published: (2004-06-01)

Contributors to Secondary Osteoporosis in Patients Referred for Treatment with Teriparatide
by: İnan Anaforoğlu, et al.
Published: (2013-12-01)

Comparison between frailty index of deficit accumulation and phenotypic model to predict risk of falls: data from the global longitudinal study of osteoporosis in women (GLOW) Hamilton cohort.
by: Guowei Li, et al.
Published: (2015-01-01)

The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women
by: Pullenayegum Eleanor, et al.
Published: (2011-09-01)

TERIPARATIDE IN CONTEMPORARY TREATMENT OF OSTEOPOROSIS: EVIDENCE FROM RECENT PUBLICATIONS
by: E A Pigarova
Published: (2015-12-01)

The Effect of Teriparatide Treatment on Spinal Deformity Index in Severe Osteoporosis
by: Fatma Gül Ülkü Demir, et al.
Published: (2019-04-01)

Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment
by: Claudia Gagnon, et al.
Published: (2008-12-01)

Teriparatide Treatment in Patients with Severe Osteoporosis: Effects on Bone Mineral Density, Biochemical Parameters, Back Pain and Quality of Life
by: Alev Çevikol, et al.
Published: (2014-08-01)

Do patients perceive a link between a fragility fracture and osteoporosis?
by: Thabane Lehana, et al.
Published: (2008-03-01)

Longterm outcomes of rheumatoid arthritis patients with severe osteoporosis treated with either Teriparatide or antiresorptive treatment – an observational study
by: Barbara Hauser, et al.
Published: (2021-04-01)

Effects of teriparatide in Chinese and Caucasian women with osteoporosis: bridging study on efficacy
by: Xie Z, et al.
Published: (2019-05-01)

Normocalcemic primary hyperparathyroidism in a patient with severe osteoporosis receiving teriparatide
by: Vishal Gupta
Published: (2013-01-01)

A scoping review of strategies for the prevention of hip fracture in elderly nursing home residents.
by: Anna M Sawka, et al.
Published: (2010-03-01)

Malignant Myeloma in a Patient after Treatment for Osteoporosis with Teriparatide; a Rare Coincidence
by: Terje Forslund, et al.
Published: (2008-01-01)

An observational study to assess back pain in patients with severe osteoporosis treated with teriparatide versus antiresorptives: An Indian subpopulation analysis
by: Harvinder Chhabra, et al.
Published: (2015-01-01)

Response to teriparatide in Chinese patients with established osteoporosis: osteocalcin and lumbar spine bone-mineral density changes from teriparatide Phase III study
by: Lu C, et al.
Published: (2017-10-01)

Utility of radius bone densitometry for the treatment of osteoporosis with once-weekly teriparatide therapy
by: Harumi Nakayama, et al.
Published: (2018-03-01)

Improvement of skeletal fragility by teriparatide in adult osteoporosis patients: a novel mechanostat-based hypothesis for bone quality
by: Toshihiro eSugiyama, et al.
Published: (2015-01-01)

Analysis and reporting of stratified cluster randomized trials—a systematic survey
by: Sayem Borhan, et al.
Published: (2020-11-01)

Effects of denosumab versus teriparatide in glucocorticoid-induced osteoporosis patients with prior bisphosphonate treatment
by: Yasuaki Hirooka, et al.
Published: (2020-12-01)

Long-term safety, efficacy, and patient acceptability of teriparatide in the management of glucocorticoid-induced osteoporosis
by: Dore RK
Published: (2013-05-01)

Evaluation of Teriparatide for Treatment of Osteoporosis in Four Patients with Cystic Fibrosis: A Case Series
by: Oranan Siwamogsatham, et al.
Published: (2014-01-01)

Weekly Teriparatide Therapy Rapidly Accelerates Bone Healing in Pyogenic Spondylitis with Severe Osteoporosis
by: Akira Shinohara, et al.
Published: (2014-08-01)

Use of teriparatide in treatment of severe osteoporosis in geriatric practice: a clinical case review
by: Ekaterina N. Dudinskaya, et al.
Published: (2020-03-01)

Review of Current Real-World Experience with Teriparatide as Treatment of Osteoporosis in Different Patient Groups
by: Barbara Hauser, et al.
Published: (2021-04-01)

The Russian Council of Experts for Use of the Innovative Anabolic Agent Forsteo®(Teriparatide) in the Treatment of Severe Osteoporosis
by: Olga Mikhailovna Lesnyak
Published: (2013-10-01)

EXPERIENCE OF LONG-TERM TERIPARATIDE USE FOR THE TREATMENT OF POSTOPERATIVE HYPOPARATHYROIDISM ASSOCIATED WITH OSTEOPOROSIS IN ELDERLY PATIENT
by: G. A. Batrak, et al.
Published: (2018-11-01)